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ABSTRACT 
Background: Exposure therapy (EXP) is a first-line intervention for combat-related 
PTSD. EXP works by repeatedly exposing the patient to the feared stimuli, situation, or physical 
sensations in the absence of actual danger until the stimuli no longer evoke maladaptive 
responses. Over the past decade, multiple technologies have been introduced to augment the 
EXP process by presenting multi-sensory cues (e.g., sights, smells, sounds) to increase patients’ 
sense of presence. Exploratory research has only broadly examined the effect of odorants on the 
patient’s sense of presence during simulated exposure tasks. This study hypothesized that those 
with autobiographical memories similar to the virtual environment (VE) and those who received 
odorants would report experiencing more presence than experimental controls. Methods: 61 
veterans and civilian subjects were randomized and asked to participate in a virtual environment 
simulating a routine OIF/OEF/OND convoy. The effects of odorants and autobiographical 
memory on presence were assessed via electrodermal activity, respiration, heart rate variability, 
and self-report measures. Results: Odorants did not significantly influence presence. A 
relationship between military experience and presence, HRV, and realism was observed. 
Conclusion: Odorants did not have a statistically significant effect on presence while engaged in 
a simulated exposure task, which was inconsistent with previous research. The rationale for these 
findings and recommendations for future research are made. 
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INTRODUCTION 
Posttraumatic Stress Disorder 
Posttraumatic Stress Disorder (PTSD) has been called one of the “signature wounds of 
the Iraq war” (Tanielian & Jaycox, 2008), with prevalence currently estimated at over 13% of 
operational infantry forces and 5% of total deployed forces (Kok, Herrell, Thomas, & Hoge, 
2012). The high prevalence within operational units represents significant demand for mental 
health service providers. However, providing care for service members may be challenging due 
to stigma (Hoge et al., 2004; Kim, Thomas, Wilk, Castro, & Hoge, 2010), limited appointment 
availability (Sareen et al., 2007), and negative perceptions of care (Kim, Britt, Klocko, Riviere, 
& Adler, 2011; Sudom, Zamorski, & Garber, 2012) which appear to result in an overall 
treatment reach that is limited (Hoge et al., 2014).  
Olesen, Gustavsson, Svensson, Wittchen, and Jönsson (2012) estimated the approximate 
annual cost of PTSD to be $10 trillion dollars in Europe alone. The Congressional Budget Office 
reported the direct cost of treating PTSD in American warfighters (a minuscule subset of the 
overall US population) between 2004-2009 was approximately 1.4 trillion dollars (Bass & 
Golding, 2012). Lépine (2002) has suggested additional, indirect expenses (such as reduced 
productivity and absenteeism) increase costs associated with mental health disorders. In addition, 
PTSD is also often compounded by other medical needs (Frayne et al., 2011) as well as 
depression (Campbell et al., 2007), which further increase the financial burden tied to mental 
health.  
Some of the symptoms associated with PTSD are part of the normal reaction to trauma. 
These include difficulty concentrating or sleeping, as well as intrusive and trauma-related thoughts 
or images. Many people who experience a traumatic event naturally recover as demonstrated by a 
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decline in distress over time.  In a civilian sample, nearly 90% of adults reported experiencing a 
traumatic event, but only a small subset developed PTSD (Kilpatrick et al., 2013). A DSM-5 
diagnosis of PTSD requires symptoms to be present for at least 30 days and requires clinically 
distressing symptoms be present across five criteria, including a) exposure to actual or threatened 
death, serious injury, or sexual violence, b) intrusive symptoms, including thoughts or memories, 
c) avoidance of reminders of the event, d) cognition and mood symptoms, such as difficulty 
remembering important aspects of the event, or persistent negative expectations, and e) arousal or 
reactivity symptoms, which include irritability and hypervigilance (American Psychiatric 
Association, 2013).  
While PTSD is no longer classified as an anxiety disorder, behavioral avoidance in PTSD 
is similar to that seen in anxiety disorders such as panic or specific phobias. Avoidance of trauma-
related reminders prevents distressing memories from arising, preventing anxious and fearful 
thoughts and negative feelings associated with the traumatic memory. Unfortunately, avoiding 
thoughts and feelings associated with the event prevents those suffering from PTSD from learning 
new and more adaptive response patterns (Foa, Huppert, & Cahill, 2006; Foa & Kozak, 1986).  
Ehlers and Clark (2000) have described avoidance as a maladaptive control strategy which 
short-circuits disconfirmation of negative appraisals. This failure to allow disconfirmation results 
in the maintenance of the perceived threat. Behavioral avoidance has been seen in various 
populations with PTSD, including combat veterans (Pietrzak, Harpaz-Rotem, & Southwick, 2011), 
victims of sexual assault and abuse (Fleurkens, Rinck, & van Minnen, 2014), and motor vehicle 
accident victims (Delahanty et al., 1997). By encouraging patients to face anxiety-provoking 
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situations, thereby preventing the avoidant behavior, incompatible and erroneous information can 
be corrected with more appropriate behavioral responses that enable better daily functioning.  
Exposure Therapy 
 Exposure therapy (EXP) is an empirically supported treatment for anxiety disorders (Opriş 
et al., 2012; Parsons & Rizzo, 2008) and PTSD (Powers & Emmelkamp, 2008; Powers, Halpern, 
Ferenschak, Gillihan, & Foa, 2010). EXP is an intervention grounded in the principles of classical 
conditioning as observed by Pavlov (1902) and Watson and Rayner (1920) and is similar to fear 
extinction models used in animals (Myers & Davis, 2007). An example of classical conditioning 
in combat-related PTSD might include avoidance of crowds after experiencing the detonation of 
an improvised explosive device (IED) in a crowded market, which threatened the life of the patient. 
The goal of EXP is to extinguish behaviors that are (or have become) maladaptive, by exposing 
the patient to the anxiety or fear-producing stimulus (or a facsimile of that stimulus) without 
exposing the patient to actual danger. Stimuli constellations are often perceived as harmless to 
outside observers but serve as “triggers” or, put more formally, fear-structures that are perceived 
as highly dangerous by warfighters with PTSD. In the IED example used earlier, this constellation 
might include the scent of smoke, diesel, and body odor, accompanied by tactile vibrations and 
loud explosions. By activating these fear-structures in the absence of danger or negative outcomes, 
corrective information acts upon and modifies the pathological component of the fear structure 
until the patient no longer experiences the distressing symptoms, thoughts, or emotions. This 
process allows new information and more adaptive expectations to be learned. EXP can be 
conducted both imaginally (where the patient imagines the feared stimulus or situation), and in 
vivo (in life, where people are physically engaged with a facsimile of, or the actual feared stimulus 
or situation).   
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Including multiple sensory modalities during EXP (either imaginal or in vivo) that are 
associated with the stimulus or situation appear to enhance learning (Rescorla, 2006). Recently, 
researchers utilizing EXP for PTSD have increased utilization of multimodal sensory systems 
during EXP to create high fidelity virtual environments (VEs) for use in EXP (Gerardi, Cukor, 
Difede, Rizzo, & Rothbaum, 2010; McLay et al., 2011; Rizzo et al., 2009; Rizzo, Reger, Gahm, 
Difede, & Rothbaum, 2009). These multi-sensory systems include 3D visuals, sounds, tactile 
feedback (platforms that vibrate during explosions, for instance), and odorants (such as the scent 
of diesel fuel). The inclusion of multiple stimuli serves multiple purposes, which includes reducing 
mental strain required to imagine or visualize the event, and reducing patient avoidance. Both 
behavioral and cognitive avoidance are common in patients with PTSD and counteract the 
theoretical mechanisms of EXP by limiting exposure to conditioned stimuli (CS) in the absence of 
unconditioned stimuli (US). The direct delivery of multisensory and trauma-related cues helps to 
circumvent patient avoidance. The inclusion of multiple trauma-related stimuli may also increase 
a patient’s degree of presence during EXP. 
Presence 
 Presence was first formally defined by Sheridan (1992) as “the sense of physically being 
present with visual, auditory, or force displays generated by a computer.” He proposed that 
presence is a subjective state produced when subjects are provided high-fidelity sensory 
information, the ability to change the environment, and willingness to engage with the VE. The 
term presence is not unified in its use, and several competing definitions and conceptualizations 
exist, which are examined in Lombard and Ditton (1997) and more recently, Procci (2015). 
These conceptualizations include presence as realism, or the capability of a system to produce 
high fidelity reproductions of real-world objects (Hatada, Sakata, & Kusaka, 1980; Neuman, 
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1990). The conceptualization of realism defined presence as a system’s ability to create virtual 
objects that have high degrees of fidelity to their real-world counterparts. Presence has also been 
thought of as transporting an audience to another time/place through various mechanisms (e.g., 
narratives, storytelling, or television) where users feel as though they are physically somewhere 
they are not (Biocca & Delaney, 1995; Gerrig, 1993; Minsky, 1980; Reeves, 1991). Presence as a 
social actor (Lombard, 1995) is perhaps one of the conceptualizations public consumers are most 
familiar with, though they may not be aware of it. Many smartphones currently implement 
virtual assistants (e.g., Apple’s Siri, Microsoft’s Cortana, and Amazon’s Alexa) capable of 
“interacting” with users. According to the social actor conceptualization, users who interact with 
these programs, as they would with actual people, experience presence. Presence has also been 
conceptualized as (and sometimes used interchangeably with the terms) perceptual or 
psychological immersion (Lombard & Ditton, 1997). Contemporary definitions of presence state 
that presence is caused by (as quoted in Procci, 2015, p. 247): 
• …high levels of overall immersion, a combination of:  
• Immersive cues provided by the video game (e.g., high-fidelity, increased field of 
view, HMD, naturalistic inputs, etc.)  
• Lots of immersive cues make it easier to confirm and needs more distractions to take 
away  
• Personal involvement and motivation to be present  
• Creative imagination and willingness to suspend disbelief  
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As the definitions of presence and immersion solidified in the early 2000’s, the accurate 
measurement of presence began to be explored. IJsselsteijn, De Kort, Poels, Jurgelionis, and 
Bellotti (2007) reviewed methodologies used to assess presence, including subjective and 
objective methods. Subjective measurements included self-report rating scales and 
psychophysical ratings. Several self-report measures are currently in use for measuring presence, 
including the Presence Questionnaire (Witmer & Singer, 1998) and the iGroup Presence 
Questionnaire (Schubert, Friedmann, & Regenbrecht, 2001). For psychophysical ratings, users 
are asked to determine if a location in a photo is real or that of a VE (Schloerb, 1995); however, it 
is important to note that the psychophysical rating method has been criticized in its ability to 
assess presence rather than simply an ability to judge images as rendered or real (IJsselsteijn et 
al., 2007). One important point offered by IJsselsteijn and colleagues is that subjective measures 
often fail if participants or subjects fail to understand the definition of presence and that 
objective measures that correlate to subjective measures are useful when assessing presence. The 
authors specifically noted the use of physiological measures to quantify presence, such as heart 
rate (HR) and galvanic skin response (GSR; now referred to as electrodermal response activity or 
EDA). The rationale for these two specific physiological methods is EDA’s association with 
arousal, and HR’s association to hedonic value, in which pleasant stimuli decrease heart rate and 
aversive stimuli increase heart rate. Unfortunately, the value of EDA is unknown, as mixed 
results have been reported in the literature (Drachen, Nacke, Yannakakis, & Pedersen, 2010; 
Wiederhold, Davis, & Wiederhold, 1998).  
It has been argued that presence is of critical importance when using VEs in 
psychotherapy (Sanchez-Vives & Slater, 2005) but the relationship between presence and VEs 
utilized in exposure therapy is currently poorly understood. Which elements are critical to evoke 
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a presence response, and what fidelity is required? Display parameters, visual realism, sound, 
haptics, body representation, and engagement have been the most explored areas pertinent to 
presence (see Sanchez-Vives & Slater, 2005 for a review), while olfaction’s effect on presence 
has generally received less attention (Aiken & Berry, 2015). 
Olfaction 
The ability to smell is found in almost all animal species (Wilson & Stevenson, 2006). 
Olfaction provides information that is particularly important in many daily functions, such as the 
detection and identification of food.  Scents or odorants may be environmental (soil, minerals) or 
biological (pheromones). Simply stated, the primary function of the olfactory system is to permit 
an organism to identify odorants. This is accomplished through receptor cells and membranes 
that respond to chemical molecule compositions. For some odorants, the amount of chemical 
required for detection can be minuscule but can provide critical information relevant to the 
organism’s survival. While seemingly simple, the process of olfaction is mechanically complex, 
and the perception of odorants depends on not only on the detection of chemical compounds but 
also one’s expectations and contextual information.  
   
 
8 
 
 
Figure 1: Schematic Diagram of the Olfactory System 
Note: The connection between olfactory bulb and the hypothalamus is not established in humans. Used 
with permission by Cambridge University Press. 
Olfaction begins within the nasal cavity at the olfactory bulb, where 5-15% of inhaled air 
is diverted towards receptors (Keyhani, Scherer, & Mozell, 1995).  There are an estimated six 
million olfactory receptor cells within each nostril (Moran, Rowley III, Jafek, & Lovell, 1982), 
which are situated in the olfactory epithelium (Figure 1). These cells are the primary receptors of 
the olfactory system and serve sensory information to the olfactory bulb, which filters and 
modifies sensory information.  
Information is then sent from the olfactory bulb to the primary olfactory cortex (POC) 
and the amygdala. The POC is comprised of the 1) anterior olfactory nucleus, 2) piriform and 
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peri amygdaloid cortices, 3) olfactory tubercle, and 4) entorhinal cortex. The anterior olfactory 
nucleus appears to regulate information flow between regions dealing with olfactory information 
(Brunjes, Illig, & Meyer, 2005). The piriform cortex has been implicated in odor recognition 
(Dade, Zatorre, & Jones‐Gotman, 2002; Plailly et al., 2005), representation of odor properties 
(Gottfried, Winston, & Dolan, 2006), odor valence (Gottfried, Deichmann, Winston, & Dolan, 
2002) and odor attention (Zelano et al., 2005), while the peri amygdaloid and entorhinal cortices 
assist in the processing of olfactory information (Biella & de Curtis, 2000; Majak & Pitkanen, 
2003). Information processed by the POC is then passed to the thalamus and hippocampus, while 
other information is passed directly from the olfactory bulb to the amygdala.  
The olfactory system has the most direct connection to the hippocampus (synaptically) 
compared to all other sensory systems. It is largely accepted that the hippocampus is involved in 
the formation of memories about experienced events (Burgess, Maguire, & O'Keefe, 2002; 
Eichenbaum, 1993). It has also been suggested that the hippocampus and amygdala act in unison 
when emotion and memory are connected. Phelps (2004) describe the amygdala’s function in 
modulating the encoding and storage of hippocampal-dependent memories. This is in addition to 
the hippocampus’ influence on amygdala responses when emotional stimuli, such as those 
encountered during traumatic events, are presented. 
The power of odorants is often anecdotally discussed when discussing memories. It has 
been suggested that scents are strong cues for memories past, a connection first described in 
Swann’s Way (Proust, 1925). Research has demonstrated that odorants result in memory recall 
with greater emotional potency than verbal or visual stimuli (Chu & Downes, 2000; Chu & 
Downes, 2002; Herz, 1998; Herz & Cupchik, 1995; Herz & Engen, 1996). The connection 
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between odorants and memory has, more recently, been leveraged in exposure therapy with 
combat veterans. For warfighters who served in OIF/OEF/OND, odorants such as cordite, 
burning rubber, garbage, and diesel fuel have been used (Rizzo et al., 2010; Rizzo et al., 2008). 
The effect of war-related odorants on veterans is not new; Kline and Rausch (1985) described 
how war-related odorants served as precipitants of flashbacks in Vietnam veterans. More 
recently, Vermetten and Bremner (2003) presented a vivid example of the emotional impact 
odorants can have when paired with traumatic events: 
I found my wife out on the back deck watching a fire that was about 300 feet 
away. This is when I noticed the smell of burning rubber, together with a faint smell of 
fuel oil or diesel oil. My wife stated she was worried about me because I was standing on 
the deck as if I was daydreaming for some minutes without responding to her. The smell 
brought to my mind the image of this burning Amtrak, again so vivid. The Amtrak was 
hit. The front door/ramp was open; both crew hatches were open and pouring out smoke 
and flame. Thick, black, acid smoke was boiling out of the troop compartment. There was 
an overpowering smell of burning rubber. I remember that smell and what it looked like 
that day vividly. There was nothing I could have done to save the people in the Amtrak. 
Fifteen Marines and three crew members died there that day. I felt the same hopelessness 
as I felt that day. I felt bad in my stomach, got a headache, and had a feeling of futility or 
finality when I thought about that incident (page 203, paragraph 3). 
While the link between odorants and memory appears to be generally accepted, little 
research has focused on the effect of odorants on veterans’ sense of presence during EXP. While 
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odorants have been shown to increase presence in more general VE’s (Dinh, Walker, Hodges, 
Song, & Kobayashi, 1999), the study did not examine the link within a treatment specific context. 
Memory 
Autobiographical memory has been defined as the mental representation of events from 
one’s past and includes semantic information about one’s self (Conway, 2005). Those with 
PTSD are often able to recall vivid details about their respective traumatic events. When 
discussed, it appears that presence is often assessed with little regard to a users’ autobiographical 
experience or memory within the virtual environment. Instead, the extant literature appears to 
examine a user's ability to recall aspects of a virtual environment after an experiment which 
manipulated odorants has concluded. For example, Dinh, Walker, Hodges, Song, and Kobayashi 
(1999) examined sensory factors that increased user’s recall of a VE. Similarly, researchers have 
compared perceived presence between real, HMD, and audio-only conditions, but failed to 
address previous experience (Mania & Chalmers, 2001). Limited research has only anecdotally 
noted significant differences in combat-related behaviors which trended with actual experience, 
which may suggest memory or experience is drawn upon by users when engaging with a VE 
(Kaber et al., 2013). Unfortunately, presence was not a variable of interest within that study. This 
dearth of information regarding the effect of memory or experience upon presence is important 
for clinical interventions based on exposing a patient to a VE rooted in autobiographical 
memory.   
Understanding the relationship between memory, presence, and olfaction may result in 
improved intervention planning and treatment outcome. If personal experience influences 
presence, special attention may be required to ensure the deployment of VE’s congruent with 
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patient memories. Similarly, if odorants enhance the sense of presence in veterans and service 
members in an environment during simulated exposure tasks, it seems logical that exposure 
therapy may be more effective when olfactory cues are added. This study hypothesized the 
following: 
1) Participants who received odorants during a simulated task would 
experience greater levels of presence than those who did not receive 
odorants. This finding would replicate the findings of Munyan, Neer, 
Beidel, and Jentsch (2016).  
2) Participants who received odorants during simulated tasks would have 
differing levels of physiological activity than those who did not 
receive odorants. It was expected that increased presence might place 
an increased demand upon the autonomic nervous system, which may 
then be observed via increased anxiety and/or arousal. 
3) Veterans would experience greater levels of presence than noncombat 
civilian controls, regardless of odorant condition. We expected that 
combat experience or autobiographical memory similar to the VE 
would cause participants to feel greater presence than those without 
similar experiences.  
4) Veterans would experience greater EDA levels and HRV than 
noncombat civilian controls, regardless of odorant condition. We 
expected veterans would engage with the VE to a higher degree than 
their noncombat peers given their experience in potentially dangerous 
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situations. We believed their experience in real-world combat zones 
might have driven increased ANS activation. 
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METHODS 
 This study asked participants to navigate a VE identical to those currently being used in 
the treatment of combat-related PTSD (Rizzo, Hartholt, Grimani, Leeds, & Liewer, 2014). We 
immersed the user in a mildly anxiety-producing situation (a military convoy along a potentially 
dangerous route) in order to simulate the arousal seen in patients during exposure therapy, albeit 
at a non-clinical level. After the informed consent process, participants completed questionnaires 
to acquire demographic information as well as data related to their immersive tendencies and 
state anxiety. They were then fitted with electrodes connected to the physiological recorder and 
assisted into the virtual reality equipment by experiment staff. The initial virtual area participants 
experienced allowed them to familiarize themselves with the head-mounted display (HMD) prior 
to the experiment beginning. After a five-minute baseline period, pre-recorded instructions were 
delivered to the participant via headphones. Once they indicated that they were ready to begin, 
the exposure task began. The VE exposure task lasted approximately 10 minutes. 
Veteran participants and civilian noncombat controls were randomized to either an odorant 
condition or a control (no odorant) condition (See Figure 2). 
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Figure 2: Experiment Design 
Participants 
Online and community announcements were made in the Orlando, Florida area. 
Recruiting announcements included flyers and announcements to online veterans, military, and 
community groups as approved by the IRB. A total of 232 potential participants completed the 
online prescreen assessment. Reasons for disqualification included the following: 18 had PCL-5 
scores above the utilized cutoff of 33, 17 were ineligible due to tobacco use, 5 reported current 
illness during the experiment window, 4 reported some degree of anosmia, and 2 had a history of 
seizures and/or epilepsy. Of the remaining potential participants, 125 did not return requests 
made by the experimenter to schedule participation times. Participant flow can be seen in Figure 
3.  
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Figure 3: Participant Flowchart 
 The final sample consisted of 61 adult males between the ages of 17 and 61 (M = 25.2, 
SD = 9.68.)  The sample was predominately white (61%) and included participants of Latino 
(13%), Asian (11%), Black (7%), and other (8%) races. Demographic information can be viewed 
in Table 1.  
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Table 1: Demographic Information 
Race n   Military Branch (if applicable) n 
White 37   Army 15 
Latino 8 
 
Air Force 4 
Asian 7   Marines 3 
African American 4 
 
Navy 3 
Other 3     
 
American Indian or Alaska Native 1 
   
Native Hawaiian or Pacific Islander 1     
 
Education n 
 
Marital Status n 
High School Diploma / GED 37   Single/Never Married 43 
Associates Degree 15 
 
Married 14 
Bachelor’s Degree 4   Divorced 4 
Graduate Degree 5 
   
          
 
Both the military and civilian control groups were queried about previous experiences 
that may have been similar to the VE to ensure distinctiveness between-groups and verify the 
degree of fit between the VE and the participants' background. For example, those with military 
backgrounds were asked to report the number of times they had deployed, their total time spent 
deployed, where they deployed, and other details pertaining to their service as they related to the 
VE. All veteran or military participants reported taking part in convoy operations during 
deployments to the Middle East in support of operations OIF/OEF/OND. Within this sample, 
52% reported deployments to Iraq (n = 13), Afghanistan (n = 7, 28%), and other countries in the 
region (n = 5, 20%). Discrete periods of overseas deployment ranged from one to seven (M = 
2.04, SD = 1.45) with total time spent deployed ranging from 6 to 48-months (M = 12.16, SD = 
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23.46). Within the military groups, 72% reported the primary vehicle utilized during convoy 
operations was a HUMVEE or a HUMVEE variant (n = 18). 
Similar questions were asked of the civilian control sample to ensure no analogous 
experiences might confound data analyses. Specifically, civilian controls were asked if they had 
been employed in any position that entailed driving or commuting long distances. No control 
participants endorsed a history of such employment. Control participants were also asked if they 
had ever served in a capacity that may have exposed them to traumatic events, such as an EMT, 
first responder, firefighter, or police officer. Again, no controls endorsed employment or 
personal experience within these fields of work/training. 
Measures 
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) 
The Clinician-Administered PTSD Scale (CAPS) for DSM-5 (Weathers et al., 2013) was 
used to assess PTSD symptomology in participants.  The CAPS interview is a 30-item 
semistructured interview used to assess both the frequency and intensity of PTSD symptoms and 
is the “gold standard” for assessing PTSD symptoms. The CAPS was administered to 
participants scoring a 33 or greater on the PCL-5 (see below) to determine if participants were 
experiencing symptoms with intensity and frequency consistent with PTSD. Scores obtained on 
the CAPS were not used for inclusion/exclusion decisions. Instead, DSM-5 diagnostic criteria 
were used to determine clinical appropriateness for this study. 
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PTSD Checklist for DSM-5 (PCL-5) 
 The PTSD Checklist for DSM-5 (PCL-5; Blevins, Weathers, Davis, Witte, & Domino, 
2015) is a 20-item self-report that assesses the 20 symptoms of PTSD in accordance with DSM-5 
diagnostic criteria. The PCL-5 is frequently used for monitoring symptom change and screening 
for PTSD. Symptom severity scores range from 0-80, with each item being rated 0 (none) to 4 
(all the time). The PCL-5 was administered for all participants as a PTSD screening measure. 
Those who scored above a 33 (Wortmann et al., 2016) were further assessed via the CAPS by the 
principal investigator.  
Quick Smell Identification Test (QSIT) 
The QSIT (Sensonics, Inc., Haddon Heights, NJ) is a 3-item, forced-choice test that uses 
microencapsulated odorant strips to determine olfactory function (Doty, Shaman, Kimmelman, & 
Dann, 1984) and is capable of detecting unsophisticated malingering, partial anosmia, and total 
anosmia. The QSIT allows researchers to identify individuals who possess abnormal olfactory 
function that may otherwise confound experimental results. 
State-Trait Anxiety Inventory (STAI) 
The State-Trait Anxiety Inventory (Spielberger, 1983) is a 40-item, self-report measure 
designed to measure both the transient state of arousal subjectively experienced as anxiety and the 
more constant emotional presence of anxiety. It has good psychometric properties (Speilberger & 
Vagg, 1984) and has a response burden of approximately ten minutes. The STAI assesses items 
based on a four-factor structure comprised of two primary factors: state anxiety and trait anxiety. 
Items on the STAI range from “I am Calm” (State Anxiety) to “I worry too much over something 
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that doesn’t matter” (Trait Anxiety). The trait anxiety portion of the STAI served as a covariate 
for trait anxiety. 
Igroup Presence Questionnaire (IPQ) 
The Igroup Presence Questionnaire is a 14-item self-report questionnaire designed to 
measure presence utilizing a 7-point Likert scale (Schubert et al., 2001) that loads onto three 
subscales; spatial presence (the sense of physically being in the virtual environment), involvement 
(focus on the VE and involvement experienced), and experienced realism (subjective realism of 
the VE). The involvement and experienced realism subscales may be particularly relevant to 
exposure therapy as VR seeks in engage patients in a realistic way. Items range from “How aware 
were you of the real world while navigating in the virtual world?” to “How real did the virtual 
world seem to you?” IPQ scores were the primary outcome measure for this study. 
Immersive Tendencies Questionnaire (ITQ) 
The Immersive Tendencies Questionnaire (Witmer & Singer, 1998) is a 29-item self-report 
measure designed to assess individual tendencies towards immersing in different mediums, such 
as books, television, and video games. The items in this questionnaire measure the participant’s 
involvement in many different daily activities, such as watching television, reading books, or 
enjoying movies. As involvement can result in more immersion, those who become more involved 
may also have greater immersive tendencies. The ITQ served as a covariate in presence-related 
analyses unless otherwise indicated. 
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Presence Visual-Analogue Scale (PVAS) 
Participants were asked to rate their level of immersion during the experiment to determine 
presence on a visual-analog scale (VAS). Visual analog scales have been demonstrated to 
accurately assess anxiety (Davey, Barratt, Butow, & Deeks, 2007). It has been shown that VASs 
have moderate to strong correlations with Likert-based items (Hasson & Arnetz, 2005). VASs have 
superior metrical characteristics than discrete scales and can have a wider range of statistical 
methods applied to their measurements (Reips & Funke, 2008). 
Presence Rating Scale (PRS) 
Participants were asked to rate their current level of presence during scripted events within 
the exposure task. This rating was on a 7-point Likert scale to remain consistent with the Likert 
scale of the IPQ. The question, “How present do you feel?” was anchored at one (not at all) and 
seven (very much). The PRS was assessed verbally as to minimize the disruption of assessing 
presence during an experimental task, which can actually reduce perceived presence if done in an 
intrusive manner (such as visually).  
Simulator Sickness Questionnaire (SSQ) 
The Simulator Sickness Questionnaire was developed by Kennedy, Lane, Berbaum, and 
Lilienthal (1993). It is a 16-item self-report scale used to rate common symptoms of simulator 
sickness on a 4-point scale. Such symptoms include general discomfort, headache, eyestrain, 
sweating, and vertigo. Information about the user’s present state of health was solicited before and 
after utilizing the VR equipment to assess symptoms commonly associated with VR use. The SSQ 
was used to ensure participant health was not compromised as a result of research participation. 
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Electrodermal Activity (EDA) 
EDA measures the electrical conductance of the skin, which is made possible by sweat 
glands controlled by the sympathetic nervous system. EDA was used as an objective measure of 
psychophysiological activity and was assessed utilizing a Mindware MW3000A Bio-Potential 
and EDA Monitor. Silver-chloride cup electrodes were placed on the nondominant palm in 
accordance with best practices (Carlson, 2013). Data were collected with BioLab Acquisition 
Software and inspected visually during the experiment by either the principal investigator or a 
research assistant trained by the principal investigator. After the experiment, the signal was 
amplified 10x and processed through a 1 Hz Low Pass filter to remove artifacts caused by 
movement. All physiological data were inspected, corrected, and analyzed in EDA (Mindware 
Technologies LTD, Gahanna, OH) by the principal investigator. EDA served as an objective, 
physiological indicator of anxiety and sympathetic nervous system activation. Skin Conducance 
Reactions (SCRs) were defined as a 0.05uS increased between between 1-3 seconds post event. 
Heart Rate Variability (HRV) 
 HRV is perhaps most simply described as the variation between heartbeat intervals. In 
recent years, HRV has been utilized as a selective index of parasympathetic control (compared to 
EDA, which is widely under sympathetic control). We assessed activation of both the 
sympathetic and parasympathetic influences on the autonomic nervous system to gain insight 
regarding the olfactory stimuli physiological influence. HRV was assessed with a MW3000A 
Bio-Potential Monitor. HRV served as a second objective, physiological indicator of anxiety, 
with less variability indicating an increased parasympathetic response. Specifically, respiratory 
sinus arrhythmia (RSA) was assessed, which is the naturally occurring variation in heart rate 
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during the breathing cycle. RSA serves as a measure of parasympathetic nervous system (PNS) 
activity. High-Frequency Power (HF/RSA Power) was used as a frequency-domain measurement 
to observe the 0.15 to 0.4 Hz band, which is thought to indicate PNS activity. 
Odorant Ratings (Intensity, Valence, Familiarity) 
 Subjects were asked to rate the intensity, valence (pleasantness), and familiarity of the 
odorants using a 7-point Likert scale anchored at -3 (Extremely Unpleasant) to 3 (Extremely 
Pleasant). Intensity (Undetectable, Intolerable) and familiarity (Unfamiliar, Very Familiar) were 
rated on a similar 7-point scale.  
Qualitative Feedback 
 Military participants were asked to provide feedback about the virtual environment. 
Specifically, they were prompted to provide insight into the degree to which the VE was 
consistent with their actual experience. This feedback allowed us to determine which aspects of 
the VE were effective and which elements may be improved upon for future research. Elements 
are deemed ineffective if they were distracting, out of place, incorrect, or otherwise detracted 
from the user experience. 
Procedures 
Informed consent was obtained by approved study personnel prior to participation as 
approved by the University of Central Florida (UCF) Institutional Review Board. Confidentially 
and its limits was reviewed prior to the pre-screen assessment as well as prior to experimental 
participation. Rights, including the right to withdraw, were discussed to ensure subjects 
understood prior to data collection. Participants were provided ample time to ask questions 
during informed consent and throughout each stage of the experiment if needed. 
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Following consent, subjects were asked to complete self-report measures and 
demographic questionnaires on an Amazon Fire 7” tablet (Amazon Inc, Seattle, WA.) They were 
then connected to the MW3000A physiological recorder and equipped with the VR equipment. 
After the experimenters ensured all systems were functioning correctly, volunteers were given a 
five-minute baseline period to familiarize themselves with the HMD and the VE.  After this 
baseline period, they were informed that the experiment would begin momentarily and given the 
following set of instructions: 
We are going to begin. During the experiment, we are going 
to present you with a virtual reality scene. Elements of the environment 
will be described to you in detail. Your job is to imagine yourself in the 
environment exactly as it is presented.  Please remain focused on the 
scene; particularly, do not imagine anything that would make you feel 
more comfortable or relaxed.  At certain points, you will be asked to rate 
how much you feel you are immersed in the environment or in other 
words, how much you feel you are really there.  We will use the 1 to 7-
point scale where 1 is “not at all” and 7 is where you feel “completely” 
immersed.  When you are asked for your rating, try to give me the rating 
as truthfully and as quickly as possible.  Your rating is very important. 
You will be notified when the experiment is over and given further 
instructions. Do you have any questions before we begin? 
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Baseline physiological data was collected during a discrete 5-minute period. The last 60 
seconds of the baseline window was utilized as a control for physiological analyses to control for 
individual differences. Physiological data was collected continuously over the duration of the 8-
minute exposure simulation, as seen in Figure 4. 
 
Figure 4: Experimental Task Timeline 
Virtual Reality System 
The odorants used were ceramic pellets impregnated with scented oil (Dreamreapers Inc., 
Melrose Park, IL). Scents were those commonly utilized in exposure therapy for combat-related 
PTSD, including diesel fuel, garbage, smoke, and body odor. Air charged with odorants was 
delivered via air dispersion by a USB controlled Scent Palette (Virtually Better Inc., Decatur, 
GA). During the experimental trial, 50% (n = 30) of participants received odorants congruent 
with the VE; the other half (n = 31) of participants did not receive odorants.  
The VE (Bravemind, Institute for Creative Technologies, USC, Pasadena, CA) was 
modeled in 3D and controlled with the Unity3D engine (Unity Technologies, San Francisco, CA) 
and approximated a military convoy as it traveled through urban and rural environments 
approximating those of Iraq and Afghanistan. Participants were asked to imagine that they were 
on a convoy mission which included visual and auditory cues such as burning trash, ambient 
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noises, and other environmental factors. The VE was presented to the subject using a Sony 
HMZ-T3 HMD (Sony Corp., Tokyo, Japan) and high-fidelity stereo headphones (Audio 
Technica ATH-M50x; Audio Technica, Stow, Ohio). The VE was presented by a PC with an 
Intel® i5-4670 3.4 GHz CPU, 16 gigabytes of RAM, and a Nvidia® GTX 780 Tic GPU. 
Participants were navigated through the VR environment at a pace matched to auditory 
descriptions of the scene. Participants did not have navigational control of their avatar for this 
experiment. Scripted events were presented to add realism to the VE. For example, a helicopter 
and A10 Thunderbolt flew over participants with a matching audio sample. Later, a burning 
vehicle on the side of the road was displayed as the participant passes an urban environment. For 
those in the odorant condition, this scene was augmented with the scent of smoke. Upon 
completion of the VE task, participants were assisted out of the physiological and VR equipment 
and then asked to complete questionnaires regarding their experience within the VR. Upon 
completing these questionnaires, volunteers received either SONA credit or an Amazon gift card 
as compensation, concluding their participation in this study.  
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RESULTS 
Statistical Analyses 
All statistical analyses were conducted on the final sample (n = 61) using JMP Pro 13.0.0 
(SAS Institute Inc., Cary, NC) after screening for data normalcy. All analyses defined 
significance with a p-value ≤ 0.05 unless otherwise specified. All Linear Mixed Models (LMMs) 
utilized a Kackar and Harville (1984) correction to reduce bias and correctly estimate standard 
errors for the utilized sample size.  
Data Screening 
Jackknife distance measures were calculated to identify multivariate outliers utilizing the 
critical value formula recommended by Penny (1996). Two such outliers were found with critical 
values greater than 3.82. All analyses were conducted with outliers both included and excluded 
to assess their influence on the mixed model. These analysis comparisons showed that while 
outliers had a small impact upon significance p-values, they did not possess enough influence to 
alter the significance of any analyses. Thus, the outliers were included in the results reported 
here.  
To detect group differences in age, a one-way ANOVA was used which revealed 
statistically significant differences between participant groups, F(3,56) = 15.97, p < 0.0001. A 
Tukey-Kramer HSD was used to further delineate where these group differences were while 
protecting the analysis error rate, and showed that the military/veteran groups were both 
significantly older than their respective civilian control groups. No differences were found 
between odorant condition groups for either the Veteran or Control groups. Age values for each 
group can be seen in Table 2.  
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Table 2: Age Differences by Group 
Group n Mean Std Error Lower 95% Upper 95% 
 
1. Veteran - 
Odorant 
11 32.0909 2.1999 27.684 36.498 A 
2. Veteran - No 
Odorant 
14 35.2143 1.9981 31.213 39.215 A 
3. Control - 
Odorant 
19 20.5789 1.6739 17.226 23.932 B 
4. Control - No 
Odorant 
17 19.3529 1.7696 15.808 22.898 B 
Note: Groups not connected by the same letter are significantly different. 
Chi-Square tests were then utilized to explore demographic differences between groups. 
With respect to ethnicity, no significant differences were found (χ2 18, n = 61,) p = 0.53. 
Significant differences were found for level of education (χ2 9, n = 61,) p = 0.002, with veterans 
having completed more bachelor and graduate degrees than the civilian sample. Significant 
differences were also found with respect to marital status (χ2 6, n = 61,) p < 0.0001, with veterans 
being married and divorced significantly more than the civilian, student population. A significant 
difference was also found for ITQ scores, F(3,57) = 2.913, p = 0.042, which suggested veterans 
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were less likely to experience presence as seen in Figure 5. 
 
Figure 5: IPQ Scores by Group 
Preliminary Analyses 
A series of t-tests were conducted comparing the odorant and no-odorant military groups 
to isolate the effect of odorant on users’ sense of presence consistent with clinical use of VR with 
odorants in the treatment of combat-related PTSD (Beidel, Frueh, Neer, & Lejuez, 2017). No 
significant differences were found between odorant conditions, indicating those with military 
backgrounds experienced similar levels of presence regardless of odorant condition, t(23) = -
0.134, p = 0.894. These results were mirrored in the civilian groups as well, with odorants failing 
to make a significant difference in reported presence on the IPQ, t(34) = -1.35, p = 0.179.  
Physiological data recorded over the duration of the VE was divided into eight sequential 
60-second epochs (henceforth referred to as ‘time’), with Respiratory Sinus Arrhythmia (RSA) 
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and High Frequency/RSA Power (HF/RSA) Power as the primary dependent variables. Veteran 
RSA was examined utilizing a full factorial model to identify differences between service 
members who received odorants compared to those who did not. This model revealed no 
significant differences between odorant conditions, F(1, 21.98) = 1.269, p = 0.272. EDA was 
also explored within the military groups and results indicated no significant differences in EDA 
between odorant conditions, F(1, 21.93) = 0.680, p = 0.418. Taken together, these findings 
indicated that within those subjects with military experience, odorants did not appear to make 
any significant difference in physiological functioning, which ran counter to this study’s a priori 
hypotheses. The combined IPQ scores can be seen in Figure 6. Thus, more complex analyses 
were then conducted to further contrast potential differences that may be attributed to odorant or 
participant experience. 
 
Figure 6: Combined IPQ Scores 
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Full Model Analyses 
Presence 
The first scientific aim of this study was to determine if the delivery of odorants 
increased perceived presence for the entire duration of the VE task. A 2x2 ANCOVA examining 
presence scores on the IPQ, while covarying for scores on the ITQ, failed to find statistically 
significant differences between those who received odorants and those who did not, F(4, 56) = 
0.965, p = 0.329, r2 = 0.11. This result indicated that statistically, each group experienced similar 
levels of presence regardless of odorant condition. Presence ratings on the VAS were also 
examined utilizing an identical ANCOVA. While this result was closer to reaching statistical 
significance (F(4, 56) = 1.959, p = 0.167, r2 = 0.10), definitive differences were absent. 
Examination of group means did reveal a pattern of scores consistent with H1, with those 
receiving odorants reporting greater presence (LSM = 69.89, SE 3.79) than those who did not 
receive odorants (LSM = 62.57, SE = 3.59).  
A 2x2 ANCOVA was then utilized to explore the IPQ subscales that include Spatial 
Presence, Involvement, and Realism. No significant differences were found for Spatial Presence 
(F(4, 56) = 1.258, p = 0.29, model r2 = 0.08) or Involvement (F(4, 56) = 0.532, p = 0.71). A 
significant difference for background was found when examining Realism (F(4, 56) = 8.597, p = 
0.004) which indicated that those with a military background perceived the VE to be more 
realistic (LSM = 17.43, SE = 0.79) than their civilian peers (LSM = 14.31, SE = 0.65) regardless 
of odorant condition.  
  Three scripted events were included within the virtual environment which included (1) 
passing a grove of palm trees, (2) an RPG attack on the lead vehicle of the convoy, and (3) 
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crossing beneath a potentially hostile bridge. Participants were prompted after each event during 
the VE to verbally provide their current presence rating on a scale of 1-7 (seven being “most 
there”). For the palm grove event (event one), no significant effects for odorant (F(4, 55) = 
0.668, p = 0.417) or the background*odorant interaction (F(4, 55) = 1.646, p = 0.204) were 
found, though a main effect for background approached significance (F(4, 55) = 3.29, p = 0.074). 
Analysis of the second event, which depicted an enemy RPG strike against the first vehicle 
immediately ahead of the participants vehicle, showed a statistically significant main effect for 
background (F(4, 56) = 7.546, p = 0.008), indicating that those with military backgrounds 
perceived higher presence (LSM = 5.65, SE = 0.22) during this event than the controls (LSM = 
4.82, SE = 0.11). Event three (passing under a potentially hostile bridge) had comparable results 
to event one, with both odorant and the background*odorant interaction effects failing to meet 
statistical significance. The background condition approached significance (F(4, 56) = 3.425, p = 
0.0695) with participants with military backgrounds reporting higher levels of presence (LSM = 
5.19, SE = 0.25) compared to controls (LSM = 4.57, SE = 0.20).  
Physiological Responses 
 
Heart Rate Variability (HRV) 
Linear Mixed Modeling (LMM) was used to explore the effects of odorants and military 
background on HRV, with lower HRV indicating more arousal. A main effect for background 
was identified, F(1, 55.97) = 4.707, p = 0.035, r2 = 0.81, which showed veterans had 
significantly less variation (LSM = 6.08, SE = 0.22) during the interbeat period than controls 
(LSM = 6.84, SE = 0.20). This result suggested that veterans experienced more arousal than the 
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civilian controls when engaged with the VE. Full model effects can be seen in Table 3.  A main 
effect for time was also found, F(1, 55.97) = 2.823, p = 0.007, as seen in Figure X. 
Table 3: RSA Main Effects 
   
r2 = 0.81 
Main Effect DF F Ratio p 
Background 1 4.707 0.034 
Odor 1 0.379 0.541 
Time  7 2.823 0.007 
Background*Odor 1 1.776 0.188 
Background*Time 7 0.864 0.535 
Odor*Time 7 0.932 0.481 
Background*Odor*Time 7 0.675 0.693 
 
 
Figure 7: RSA by Time 
RSA was then examined using the 60-second, post-scripted time, the results of which can 
be seen in Table 4.  
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Table 4: RSA Effects by Scripted Event 
Effects, Event 1 Sum of Squares F Ratio p 
Odorant 2.846 2.323 0.133 
Background 5.666 4.624 0.035 
Background*Odorant 7.167 5.849 0.018     
Effects, Event 2 
  
Odorant 0.271 0.143 0.705 
Background 9.004 4.772 0.033 
Background*Odorant 0.464 0.246 0.621     
Effects, Event 3 
  
Odorant 0.978 0.756 0.388 
Background 7.354 5.686 0.02 
Background*Odorant 1.922 1.486 0.227 
 
Significant effects for background and the background*odorant interaction were found 
immediately following event one. Following this event, veterans displayed significantly lower 
RSA (LSM = 6.18, SE = 0.22) than controls (LSM = 6.81, SE = 0.18). The background*odorant 
interaction indicates that the veteran group who did not receive odorants was significantly more 
aroused than the control groups, though statistically similar to the veteran odorant condition, as 
seen in Table 5. 
Table 5: Background*Odorant RSA Interaction for Event 1 
Group Least Sq Mean Std Error 
 
Veteran, Odorant 6.76 0.333 A 
Veteran, No Odorant 5.607 0.307 A 
Civilian, Odorant 6.682 0.253 B 
Civilian, No Odorant 6.944 0.268 B 
 
Note: Groups not connected by the same letter are significantly different. 
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A main effect for background was also seen immediately following event two (F(3, 56) = 
4.772, p = 0.033), during which veterans again showed significantly lower RSA (LSM = 6.04, SE 
= 0.28) than controls (LSM = 6.83, SE = 0.22). This pattern of responding continued following 
event three (F(3, 56) = 5.686, p = 0.020), with veterans displaying lower RSA (LSM = 6.25, SE = 
0.23) than their control counterparts (LSM = 6.97, SE = 0.18). 
 High Frequency/ Respiratory Sinus Arrhythmia (HF/RSA) power was also examined to 
identify differences in parasympathetic activation between groups and conditions. LMM was 
again utilized to explore the background, odorants, background*odorant interaction, and baseline 
HF/RSA effect terms. This model had an R2 of 0.44, accounting for 44% of the variance within 
the model. The a priori hypothesis stated that both those with military backgrounds, those who 
received odorants, and the military background/odorant group, would experience greater 
parasympathetic activation. This hypothesis was not supported by the data, as odorant condition 
(F(1, 55.22) = 0.013, p = 0.908, r2 = 0.41), background (F(1, 55.11) = 0.407, p = 0.526), and the 
odorant*background interaction (F(1, 55.11) = 0.086, p = 0.769) failed to reach statistical 
significance.  Further examination of the LSM for the odorant condition revealed marginally 
higher HF/RSA peak power in those who received odorants (LSM = 0.19, SE = 0.006) compared 
to those who received no smells (LSM = 0.18, SE = 0.006). Inspection of HF/RSA also revealed 
minute differences favoring those without military backgrounds (LSM = 0.19, SE = 0.005) over 
their service member counterparts (LSM = 0.18, SE = 0.006). These main effects can be seen in 
Table 6. 
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Table 6: HF/RSA Effects 
Main Effect df F Ratio p 
Background 1 0.387 0.536 
Odor 1 3.034 0.087 
Segment Number 7 0.745 0.633 
Background*Odor 1 0.318 0.574 
Background*Segment Number 7 0.919 0.491 
Odor*Segment Number 7 0.682 0.686 
Background*Odor*Segment Number 7 1.775 0.09     
 
Electrodermal Response (EDA) 
 Significant group differences were identified in baseline tonic SCL between those with 
military service and their civilian counterparts, t(58) = 2.430, p = 0.018, as seen in Figure 8. 
 
Figure 8: Baseline Tonic SLC by Group 
   
 
37 
 
Time segments utilized for RSA and HF/RSA were also examined to determine if differences 
existed within the electrodermal response, this study’s index of sympathetic nervous system 
activity. A LMM was constructed which accounted for baseline response levels, odorant 
condition, military background, and time.  When examining total SCR responses, regardless of 
the presence or absence of a scripted event, no significant differences were seen for odorant 
condition (F(1, 54.93) = 0.913, p = 0.343), background (F(1, 54.95) = 0.069, p = 0.793), or the 
interaction term (F(1, 54.87) = 0.010, p = 0.918, Table 7). This model had an R2 = 0.77 and 
indicated that participants across conditions, backgrounds, and exposure time had similar 
numbers of total SCR events, though it is probable that the constant carries the majority of the 
accounted residual. No SCRs included in this model were classified as Event-Related. 
Table 7: Total SCRs 
Effect df F Ratio p 
Background 1 0.069 0.793 
Odor 1 0.913 0.343 
Segment 7 30.137 <0.000 
Background*Odor 1 0.01 0.918 
Background*Segment 7 0.846 0.549 
Odor*Segment 7 2.687 0.01 
Background*Odor*Segment 7 1.569 0.142 
Total SCRs, Baseline 1 98.453 <0.000     
  Tonic Skin Conductance Level (SCL) was also examined to determine if odorants or 
background influenced mean SCL after removing artifacts introduced by SCRs. This analysis 
utilized the same LMM as total SCR but with SCL set as the dependent variable. After 
controlling for baseline measurements, no significant effects were found as seen in Table 8. 
These results indicate that regardless of background or odorant condition, similar levels were 
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observed. Tonic Period was also assessed to determine if participants varied in the duration of 
SCR responses utilizing this LMM. These results were not statistically significant and indicated 
similar tonic periods regardless of condition or background as seen in Table 9.  
Table 8: Tonic SCL Effects and Interaction Term Across VE  
Term DF DF Error F Ratio p 
Background 1 55.04 0.2 0.656 
Odor 1 55.03 0.218 0.642 
Background*Odor 1 55.03 2.356 0.13 
Note: Model R2 = 0.98 
Table 9: Tonic Period Effects and Interaction Term Across VE 
Term DF DF Error F Ratio p 
Background 1 55.21 1.225 0.273 
Odor 1 55.2 0.044 0.833 
Background*Odor 1 55.16 0.002 0.964 
Note: Model R2 = 0.77  
15-second time segments where analyzed utilizing a LMM. Significant main effects for Odorant, 
F(1,56) = 4.43, p = 0.039 (r2 = .99), and Background, F(1,56) = 5.83, p = 0.019 were identified, which 
suggested those who received odorants had higher SCL than those without as seen in Table 10. Further, 
veterans had lower SCL than their civilian counterparts 
Table 10: Post-Event SCL 
Effect df DFDen F Ratio p 
Odor 1 56 4.439 0.039 
Background 1 56 5.832 0.019 
Event 2 112 1.92 0.151 
Odor*Background 1 56 2.046 0.158 
Odor*Event 2 112 0.456 0.634 
Background*Event 2 112 0.893 0.412 
Odor*Background*Event 2 112 0.010 0.989 
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Note: Model R2 = 0.05 
Table 11: Mean SCL, Scripted Events 
Term DF DF Error F Ratio p 
Background 1 55 0.271 0.604 
Odor 1 55 1.311 0.257 
Background*Odor 1 55 2.56 0.115 
Note: Model R2 = 0.99 
Table 12: Tonic Period, Scripted Events 
Term DF DF Error F Ratio p 
Background 1 55 5.369 0.024 
Odor 1 55 2.837 0.098 
Background*Odor 1 55 0.39 0.535 
Note: Model R2 = 0.99 
Tonic Period was analyzed as seen in Table 12. A significant main effect was found for 
background, which indicated that those with military backgrounds spent significantly less time 
without phasic EDA (LSM = 7.6sec, SE = 1.666) compared to controls (LSM = 12.5sec, SE = 
1.353). In other words, service members’ SCRs occurred over longer periods of time, but at 
similar magnitudes, as controls. The main effect for odorants and the background*interaction 
term were not statistically significant.  
EDA was also examined pre- and post-event do identify potential differences in SCL 
immediately before and after an event. 15-seconds before and after (30 seconds total) were 
analyzed via LMM. Significant effects were found for odorants and background, but not for 
time. These results indicated that those with military backgrounds had lower SCL, and those who 
received odorants, had greater levels of SCL (Table 13). SCL trends were also examined across 
time by group. These are seen in Figure 9.  
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Table 13:Pre/Post Event SCL 
Effect df Error F Ratio p 
Odor 1 56 4.474 0.038 
Background 1 56 5.962 0.017 
Time 1 56 2.746 0.103 
Odor*Background 1 56 2.087 0.154 
Odor*Time 1 56 0.430 0.514 
Background*Time 1 56 2.322 0.133 
Odor*Background*Time 1 56 0.703 0.405 
 
Note: r2 = 0.98
 
 Figure 9: SCL Across Time 
Note: Vertical lines represent events one, two, and three, respectively. 
 A more complex pre/post event mixed model was also run to examine the effects of 
odorants and experience immediately before and after the scripted events. This analysis utilized 
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resampled data (20hz, or 20 samples per second) for ten seconds immediately before and after 
each scripted event as seen in Table 14.  
Table 14: EDA Event Analyses 
Event 1 Effects (r squared = 0.98) DF DFDen F Ratio Prob > F 
Background 1 57.29 9.186 0.004 
Odor 1 57.29 5.076 0.028 
Event 1 Effects 1 54.49 0.000 0.985 
Time 1 54.84 0.325 0.571 
Background*Odor 1 57.29 2.519 0.118 
Background*Event 1 1 54.49 0.636 0.429 
Background*Time 1 54.84 0.001 0.976 
Odor*Event 1 1 54.49 0.154 0.696 
Odor*Time 1 54.84 0.030 0.864 
Event 1*Time 1 54.51 0.004 0.948 
Background*Odor*Event 1 1 54.49 0.142 0.708      
Event 2 Effects (r squared = 0.98) DF DFDen F Ratio Prob > F 
Background 1 57 6.740 0.012 
Odor 1 57 3.846 0.055 
Time 1 57.1 2.926 0.093 
Event 2 1 57.08 0.462 0.500 
Background*Odor 1 57 2.438 0.124 
Background*Time 1 57.1 0.205 0.652 
Background*Event 2 1 57.08 1.708 0.197 
Odor*Time 1 57.1 0.108 0.744 
Odor*Event 2 1 57.08 0.868 0.355 
Time*Event 2 1 57.1 0.154 0.696 
Background*Odor*Event 2 1 57.08 0.884 0.351      
Event 3 Effects (r square = 0.99) DF DFDen F Ratio Prob > F 
Background 1 57.03 6.105 0.017 
Odor 1 57.03 4.954 0.030 
Time 1 56.77 0.000 0.998 
E3 1 56.75 0.432 0.514 
Background*Odor 1 57.03 2.897 0.094 
Background*Time 1 56.77 0.037 0.849 
Background*E3 1 56.75 0.076 0.784 
Odor*Time 1 56.77 1.384 0.244 
Odor*E3 1 56.75 0.888 0.350 
Time*E3 1 56.82 0.153 0.697 
Background*Odor*E3 1 56.75 0.238 0.628 
 
 Statistically significant main effects were observed for background and odorant 
conditions, but were absent across interactions with the dichotomous event (En) marker, 
suggesting no differences were observed as the resulting factor combination. These significant 
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differences also suggested odorants resulted in increased presence, and that civilians experienced 
greater EDA than those with military service, which was consistent with previous analyses. 
Event 1       
 Least Sq Mean Std Error   Least Sq Mean Std Error 
Odorant 12.359 1.580  Veteran 6.595 1.679 
No Odorant 7.444 1.504  Civilian 13.207 1.392 
       
       
Event 2       
Odorant 12.070 1.646  Veteran 6.888 1.751 
No Odorant 7.610 1.568  Civilian 12.792 1.451 
       
Event 3       
Odorant 12.694 1.693  Veteran 7.202 1.801 
No Odorant 7.489 1.613  Civilian 12.980 1.492 
 
MANCOVA 
 In order to fully investigate relationships within our model, multiple MANCOVA 
analyses were conducted on the main RSA and HRV datasets, which can be seen in Table 14.   
Table 15: Physiological MANOVAs 
Total SCRs df Error F Ratio P 
Intercept 1 53 107.454 <.0001 
Background 1 53 0.948 0.334 
Odorants 1 53 1.023 0.316 
Background*Odorants 1 53 3.156 0.081      
Mean SCL df Error F Ratio P 
Intercept 1 53 67.601 <.0001 
Background 1 53 5.95 0.018 
Odorants 1 53 2.951 0.091 
Background*Odorants 1 53 1.968 0.168      
Tonic SCL df Error F Ratio P 
Intercept 1 53 67.163 <.0001 
Background 1 53 5.842 0.019 
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Odorants 1 53 3.009 0.088 
Background*Odorants 1 53 1.968 0.166      
RSA df Error F Ratio P 
Intercept 1 53 1646.559 <.0001 
Background 1 53 3.333 0.073 
Odorants 1 53 0 0.996 
Background*Odorants 1 53 2.09 0.154      
HF/RSA df Error F Ratio P 
Intercept 1 53 952.859 <.0001 
Background 1 53 0.68 0.413 
Odorants 1 53 3.635 0.062 
Background*Odorants 1 53 0.205 0.652 
 
As with the LMM, general statistical support was observed for a background main effect. 
Odorants did not reach statistical significance in these analyses. Relationships between pre- and 
post-experimental STAI scores were examined as well to determine if anxiety correlated with 
physiological responses, as seen in Tables 15 and 16, respectively. 
Table 16: Pre-Exposure STAI/Physiological Correlations 
 
Pre Exposure 1 2 3 4 5 6 
1 STAI Pre Exp 1.00 
     
2 Total SCRs, Seg 1 -0.02 1.00 
    
3 Tonic SCL, Seg 1 -0.14 0.66 1.00 
   
4 Mean SC, Seg 1 -0.13 0.67 1.00 1.00 
  
5 RSA, Seg 1 -0.22 -0.22 -0.12 -0.11 1.00 
 
6 HF/RSA Peak Power, Seg 1 -0.26 -0.03 0.11 0.10 0.10 1.00 
 
 
 
 
   
 
44 
 
Table 17: Post Exposure STAI/Physiological Correlations 
 
Post-Exposure 1 2 3 4 5 6 
1 STAI Post Exp 1.00 
     
2 Total SCRs, Seg 1 -0.10 1.00 
    
3 Tonic SCL, Seg 1 -0.17 0.66 1.00 
   
4 Mean SC, Seg 1 -0.17 0.67 1.00 1.00 
  
5 RSA, Seg 1 -0.22 -0.22 -0.12 -0.11 1.00 
 
6 HF/RSA Peak Power, Seg 1 -0.09 -0.03 0.11 0.10 0.11 1.00 
  
Secondary Analyses 
Anxiety 
 Trait Anxiety scores on the STAI were examined to identify any group differences prior 
to principle analyses. An ANOVA examining STAI-Y2 (trait anxiety) did not find statistically 
significant differences between groups (F(3, 57) = 1.388, p = 0.255). These results indicate that 
each group had similar levels of trait anxiety as measured by the STAI prior to participating in 
the experimental task. A 2x2 ANCOVA was then utilized to detect differences in state anxiety 
before and immediately after engaging in the VE. This model used individual trait anxiety as a 
covariate and found the main effect for time approached significance, which indicated mild 
increases in anxiety following the VE task (LSM = 32.86, SE = 0.95) compared to baseline (LSM 
= 30.97, SE = 0.95.) No other effects approached or achieved statistical significance in this 
model as seen in Table 17.  
Table 18: State Anxiety Fixed Effect Tests 
Term DF DF Error F Ratio p 
Background 1 56 2.790 0.100 
Odor 1 56 1.224 0.273 
Time 1 57 3.419 0.069 
Background*Odor 1 56 1.674 0.200 
 Note: Model R2 = 0.78 
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Odorant Valence, Familiarity, and Intensity 
 Prior to the experiment, participants were asked to rate each odorant in terms of 
familiarity, pleasantness, and intensity. A one-way ANOVA was used to identify significant 
differences by group. No significant differences were found between groups on pleasantness, 
familiarity, or intensity. P-values for these one-way ANOVAs can be seen in Table 18, with 
individual odorant means and standard errors in Table 19. 
Table 19: One-way ANOVAs, Valence*Group 
 
Pleasantness Familiarity Intensity 
 
            p 
Smoke 0.55 0.33 0.11 
Body Odor 0.99 0.18 0.90 
Diesel Fuel 0.24 0.67 0.16 
Garbage 0.81 0.51 0.53 
 
  
 
 
 
Table 20: Odorant Valence Means by Group 
 
Smoke Body Odor 
Group Pleasant SE Familiar SE Intense SE Pleasant SE Familiar SE Intense SE 
Veteran - Odorant 5.82 0.45 5.73 0.46 4.27 0.29 5.36 0.30 3.27 0.35 3.09 0.27 
Veteran - No Odorant 5.36 0.40 5.21 0.41 5.07 0.26 5.29 0.27 3.14 0.31 3.21 0.24 
Control - Odorant 5.00 0.34 5.16 0.35 4.32 0.22 5.32 0.23 2.53 0.27 3.00 0.21 
Control - No Odorant 5.29 0.36 4.65 0.37 4.59 0.23 5.29 0.24 2.53 0.28 3.00 0.22 
 
Diesel Fuel Garbage 
Group Pleasant SE Familiar SE Intense SE Pleasant SE Familiar SE Intense SE 
Veteran - Odorant 4.09 0.38 4.00 0.46 4.45 0.23 7.27 0.34 5.45 0.29 11.00 4.09 
Veteran - No Odorant 4.50 0.34 4.50 0.40 4.29 0.20 6.93 0.30 5.07 0.26 14.00 4.00 
Control - Odorant 4.21 0.29 4.58 0.35 4.68 0.18 7.16 0.26 5.37 0.22 19.00 3.58 
Control - No Odorant 3.59 0.31 4.12 0.37 4.88 0.19 7.29 0.27 5.59 0.23 17.00 3.24 
 
 
 
 
 
  
 
 
 
Simulator Sickness 
 Simulator sickness was also examined to assess for new or worsening symptoms caused 
by the VR task. This was done by examining the effects of odorants, background, and time 
across the model. No significant differences were found for odorant condition (F(1, 57) = 0.137, 
p = 0.712) or the odorant*background interaction (F(1,57) = 0.236, p = 0.628). A main effect for 
background did approach significance (F(1,57) = 3.970, p = 0.051), indicating that those with 
military backgrounds reported a greater number of symptoms consistent with simulator sickness 
(LSM = 4.2, SE = 0.86) compared to the controls (LSM = 1.95, SE = 0.72). Previous research has 
shown that those with expertise in given situations may be more susceptible to SS (McGuinness, 
Bouwman, & Forbes, 1981). 
Attention 
 After the simulated exposure task was completed, participants answered several questions 
about stimuli that may or not have been included within the VE. These stimuli were multimodal 
in nature and included visuals (a camel, helicopter, blue and white police vehicle, and collapsed 
bridge), tactile feedback (yes/no), odorants (yes/no), and temperature changes (yes/no). This 
battery of questions served as an index of attention as it is difficult to utilize objective measures 
of attention (such as eye trackers) with current HMD technology. Overall, 100% of participants 
correctly reported receiving visuals through the HMD. A large majority (81%) correctly 
identified they experienced tactile feedback during the EXP. Most participants (77%) across all 
groups reported receiving odorants, while only 30 participants were administered odorants 
during the EXP. Those who did not receive odorants were far more accurate in determining if 
they been administered odorants than the actual odorant condition. Most individuals were also 
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correct in determining if they had been administered odorants (58%), while 62% correctly 
identified the presence of a white and blue police vehicle within the VE. Finally, all participants 
correctly identified that an object (a destroyed bridge) was not present in the scenario. The 
overall pattern of correct responses on the attention items indicated no significant differences in 
attention between groups. These results indicated all groups exerted fair effort during the 
experimental tasks.  
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DISCUSSION 
 The primary purpose of this study was to determine if odorants or military experience 
influenced users’ perceived presence during a virtual convoy in a Middle Eastern environment. 
The a priori hypotheses were that the administration of odorants, a positive history of military 
deployment, and the interaction of the two, would result in significantly higher levels of 
presence. Further, it was hypothesized that odorants and military experience would moderate 
HRV and EDA.  
 The hypotheses regarding presence were not supported by the data collected in this 
sample.  Regardless of the presence or absence of odorants, participants experienced similar 
levels of presence during the simulator exposure task. Scores on the VAS mirrored these results. 
Individual group means did trend in the hypothesized directions with those who received 
odorants reporting an average of two points higher on the IPQ, and seven points on the VAS. 
However, subscale analysis of the IPQ differed from previous research, which indicated 
significantly different scores on the involvement subscale, favoring odorants (Munyan, Neer, 
Beidel, & Jentsch, 2015).  Those with military service also reported substantially higher levels of 
realism after engaging with the VE. Increasing realism may be beneficial during psychotherapy 
if incremental improvements in CS realism translate to improving treatment outcomes. It is 
possible that the observed significant effects described here accounted for enough variance 
within the model that further effects would require additional power to detect. Raw mean 
analysis of group*odorant effects trended in the hypothesized directions but were not statistically 
significant. Another hypothesis is that the groups were more dissimilar than planned. 
  Despite previous anecdotal and empirical evidence favoring odorants, significant effects 
were far more likely to be attributed to military experience within this sample. Regarding 
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presence, main effects for a military background were found during the second scripted event (an 
RPG ambush) during which those with deployment experience were more present than controls. 
This was unexpected as we believed those with combat experience might be more critical of the 
VE. It is possible warfighters were particularly engaged with this event because of their 
experience. The urban environment may have been a “red flag” for those who have deployed, 
whereas those without military training did not differentiate between environments and their 
associated (and simulated) risk despite the included narration during the task. 
Examination of HRV also showed those who had deployed previously had significantly 
less variation during the interbeat period, indicating significantly more parasympathetic arousal 
than controls. While there was moderate support of our military background hypotheses, HRV 
analyses failed to statistically support the hypothesis that odorant would moderate RSA. We also 
hypothesized electrodermal responses of both greater magnitude and frequency in those who 
receive odorants and in participants with military experience. The data collected did not support 
either of these hypotheses. In fact, the only main effect that achieved statistical significance was 
tonic period, which indicated service member’s responses, though similar in frequency, had 
longer durations than controls. This may be a result of military training or diverse levels of 
vigilance throughout the VE. Unfortunately, this study lacked temporal resolution that would 
enable causal inferences. The lack of significant EDA differences may also be (to some degree) a 
lack of state anxiety generated by the VE. Despite scripting several potentially dangerous events 
into the VE (RPG Ambush, potential IED sites, and roadside debris), which are often specifically 
associated with danger in contemporary combat zones, reported anxiety was less than 
anticipated.  
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The lack of anxiety response within the military population may be because all military 
participants had engaged in convoy operations overseas, some with multiple deployments. This 
degree of experience may have blunted an anxiety response for many reasons. For example, 
participants may have realized that no dangerous outcome was physically possible given the 
simulated nature of the VE. Another reason for this finding may be that those with more time 
deployed had habituated to anxiety associated with military operations. This hypothesis was 
tested utilizing a bivariate analysis, which did not show a significant relationship between time 
deployed and state anxiety during the VE. The nature of our nonclinical sample may also be a 
factor; those with PTSD (and perhaps, the most to fear) were excluded from this study, which 
may introduce a ceiling effect with respect to anxiety.   
An important theoretical question also lingers; is presence required for exposure therapy 
to work? Imaginal EXP has been demonstrated to be effective repeatedly, without the use of 
virtual reality of other external stimuli. When done correctly, it is likely that presence is high and 
is thus a byproduct of the exposure when patients are actively engaged during therapy. Our 
hypotheses suggested that the addition of odorants to EXP might further increase presence, thus 
boosting patient engagement, with the hopes that increased engagement via presence may then 
result in tertiary effects, such as improved outcomes or shorter episodes of care. A similar trend 
was currently found by Mota et al. (2015), who noted that ratings of vividness during EXP 
predicted treatment outcome. A valid concern regarding the inclusion of odorants is that odorant 
specificity may be subject to the “uncanny valley” (Mori, 1970), by which incorrect stimuli may 
produce effects worse than no stimulant at all. Further research may be required to explore 
odorant specificity as it relates to EXP. 
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Participants also rated odorant valences as a part of this study, with all groups rating each 
quality (pleasantness, familiarity, and intensity) in a similar fashion.  Despite measuring odorant 
valence and individual differences in immersive tendencies, statistical evidence supporting 
anecdotal statements encountered throughout the combat-related PTSD literature was not found. 
While this study did find limited evidence that odorants increase presence and moderate RSA 
and EDA, these findings were not statistically robust enough to drive clinical decision-making. 
There are, however, several ways to methodologically improve upon this study in the future. 
 
Limitations and Future Directions 
In this study, veteran participants were nearly a decade older on average than the 
nonmilitary controls within this sample. Further, the military sample was also more likely to be 
married and have completed more formal education. While some difference in age was expected 
due to the nature of military service, which requires at least an 8-year commitment (only some of 
which must be active duty), we did not anticipate a mean difference of greater than 10 years. The 
differences between groups may also be less obvious. For instance, it is estimated that 5.2% of 
the US population has served in the armed forces (Chalabi, 2015). It has also been shown that 
soldiers are more likely to come from high-income areas and have completed more education 
than civilian peers . SES data were not collected during this study, nor would it be appropriate to 
readily interpret educational differences that existed between groups within this sample, as all 
control subjects were actively pursuing degrees at an institution of higher education. While no 
research could be identified that offered a theoretical rationale for age or education influencing 
presence, the possibility cannot be ruled out. An improved approach might include recruiting 
adults closer in age, which may then better account for both educational and marital differences 
   
 
53 
 
and better represent the broader adult population rather than the college population described 
here.  
It was also noted that 33% of participants were unable able to correctly identify if 
odorants were delivered during their experimental task. While “true negative” participants were 
more accurate identifying the absence of odorants, it is possible the odorants utilized where 
insufficient in duration or intensity during the task for certain individuals which may have 
impacted presence ratings. Similarly, no ratings of odorant fidelity were collected to determine if 
participants perceived the odorants as scene appropriate. Increased presence would likely only 
occur if odorants were high fidelity with respect to the VE.  
Temporal resolution within the study was also insufficient to permit additional analyses 
of interest. For example, comparing physiological responses during odorant administration or 
narrative delivery may have been revealing. Due to equipment limitations, “flagging” these 
events during the experiment was not possible.  
Thus far, the terms “memory,” “experience,” and “background” were used 
interchangeably. This was not in error, but rather an attempt to honestly convey the rift between 
internal and external validity whilst “bootstrapping” military participants’ deployment 
experience overseas to an artificial virtual environment to assess what we believed to be a 
somewhat common military mission. This “muddying of the waters” was unavoidable with a 
nonclinical sample who may not have experienced and perceived a convoy operation precisely as 
simulated during the exposure task. With a true clinical sample utilizing VEs designed around 
their specific traumatic event would likely experience significantly greater levels of anxiety and 
presence. Specifically, matching trauma-related odorants to trauma-focused therapy eliminates 
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the problems inherent in a well design, internally valid research study where findings may not 
generalize outside of the laboratory. Given the highly personal nature of PTSD, one might argue 
that sacrificing internal validity (by customizing odorant/trauma scenes to each subject) would 
lead to significantly more meaningful data (which would be difficult to control for, statistically 
speaking).   
Utilizing a clinical sample of individuals with actual traumatic, episodic memories and 
customizing the VE to match their individual event may be the only method to accurately assess 
the effect of odorants due to the number of variables involved in memory formation. Further, 
contrasting the clinical groups to similar military controls would be a significant improvement, 
as it would allow further control to distinguish between the effects of military training, 
deployment experience, and trauma. While this research design would be complex, the results 
may be more meaningful given the variability seen in PTSD diagnoses and mental health in 
general. This research would also serve as a meaningful leap towards exploring the true field 
value and utility of odorant augmentation during exposure therapy. 
Conclusion 
Exposure therapy continues to be a first-line intervention for anxiety and trauma-related 
disorders. Exposure therapy is already being augmented with virtual reality with great success 
(Beidel et al., 2017). However, the specific effects of odorants remain relatively underexplored. 
The contrast between odorant conditions in this study may have improved with groups better 
matched for age and education, with further emphasis on external validity. Despite the 
limitations of this study, several noteworthy findings were discovered. Those with military 
backgrounds reported the VE to be more realistic, which may prove to have utility given the 
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importance of realism during EXP. Further, service members also experienced more decreased 
RSA than controls, indicating that VEs alone may improve performance during exposure. It is 
our hope that clinicians and researchers alike will continue to embrace VE augmentation and 
research, and that future research addresses and overcomes the challenges discussed here. 
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APPENDIX A: IRB APPROVAL LETTER 
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APPENDIX B: OUTCOME VARIABLE CORRELATIONS 
 
  
 
 
 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1 ITQ 1.00                
2 IPQ -0.03 1.00               
3 IPQ (SP) -0.02 0.86 1.00              
4 IPQ (Involvement) 0.05 0.65 0.46 1.00             
5 IPQ (Realism) -0.06 0.79 0.47 0.27 1.00            
6 STAI (State, Post) -0.21 0.34 0.22 0.20 0.35 1.00           
7 STAI (State, Pre) -0.30 0.20 0.15 0.08 0.23 0.70 1.00          
8 STAI (Trait) -0.13 0.09 0.06 0.02 0.14 0.63 0.83 1.00         
9 SSQ (Pre) -0.19 0.22 0.11 0.24 0.18 0.47 0.56 0.49 1.00        
10 SSQ (Post) -0.15 0.33 0.16 0.26 0.35 0.73 0.58 0.52 0.84 1.00       
11 Anxiety (Pre) -0.19 0.20 0.04 0.14 0.29 0.76 0.72 0.68 0.46 0.61 1.00      
12 Anxiety (Post) -0.16 0.40 0.27 0.28 0.37 0.81 0.53 0.45 0.43 0.65 0.75 1.00     
13 Video Game Use 0.25 -0.04 0.00 -0.01 -0.07 -0.25 -0.14 -0.22 -0.19 -0.27 -0.21 -0.26 1.00    
14 Palm Grove  0.04 0.55 0.47 0.43 0.37 0.19 0.23 0.21 0.10 0.09 0.20 0.24 -0.09 1.00   
15 RPG Ambush  -0.02 0.64 0.50 0.35 0.56 0.24 0.08 -0.04 0.14 0.22 0.14 0.34 -0.19 0.71 1.00  
16 Bridge Rating -0.05 0.57 0.48 0.42 0.39 0.31 0.20 0.12 0.23 0.27 0.21 0.36 -0.13 0.72 0.70 1.00 
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